发明名称 |
NANOPARTICULATE SORAFENIB FORMULATIONS |
摘要 |
The present invention is directed to compositions comprising a nanoparticulate sorafenib, or a salt, such as a sorfaneib tosylate, or derivative thereof, having improved bioavailability. The nanoparticulate sorafenib particles of the composition have an effective average particle size of less than about 2000 nm and are useful in the treatment of cancer, renal cancer, and related diseases. |
申请公布号 |
WO2008008733(A3) |
申请公布日期 |
2008.05.29 |
申请号 |
WO2007US73078 |
申请日期 |
2007.07.09 |
申请人 |
ELAN PHARMA INTERNATIONAL LTD.;CARTY, SARAH;JENKINS, SCOTT;LIVERSIDGE, GARY |
发明人 |
CARTY, SARAH;JENKINS, SCOTT;LIVERSIDGE, GARY |
分类号 |
A61K9/14;A61K9/20;A61K31/4412 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|